Background

• Cystinuria is an infrequent genetic disorder characterized by the impaired transport of specific amino acids, specifically cystine, arginine, lysine, and ornithine, within the kidneys and urinary tract. The renal tubules normally reabsorb these amino acids, preventing their excess excretion in the urine. However, individuals with cystinuria have a malfunctioning transport system, accumulating cystine crystals in the urine. Over time, these crystals can aggregate and form stones, known as cystine stones or cystine calculi, which can block the urinary tract, causing severe pain and potentially leading to kidney damage if left untreated. 
• Cystinuria is typically inherited, with autosomal recessive inheritance being the most common pattern. Symptoms often manifest in early childhood or adolescence and can vary in severity, with certain individuals experiencing frequent stone formation and others only having occasional episodes. Treatment aims to prevent stone formation by increasing fluid intake, reducing dietary cystine, and using medications like thiol to reduce cystine levels in the urine.  

Epidemiology

Cystinuria is a genetic disorder characterized by the abnormal transport of cystine, an amino acid, leading to the formation of kidney stones.  

• Prevalence: Cystinuria is a rare genetic disorder with an estimated prevalence of nearly 1 in 7,000 individuals. 
• Genetic Inheritance: Cystinuria is usually inherited in an autosomal recessive manner, i.e., both parents must carry a mutated gene for a child to develop the condition. 
• Geographic Distribution: Cystinuria has a global distribution, and its prevalence may vary in different populations. 

Anatomy

Pathophysiology

Cystinuria is a genetic disorder affecting amino acid transport in the kidneys and urinary tract. The underlying pathophysiology of cystinuria is primarily related to a defect in the transport of specific amino acids, most notably cystine, but also arginine, lysine, and ornithine, within the renal tubules.  

• Impaired Renal Tubular Transport: In individuals with cystinuria, a genetic mutation affects the functioning of specific transport proteins located in the cells lining the renal tubules in the kidneys. These transport proteins are responsible for reabsorbing amino acids, including cystine, from the urine into the bloodstream. However, due to the genetic mutation, these transport proteins are dysfunctional or insufficient, reducing cystine reabsorption and other affected amino acids. 
• Excess Cystine in Urine: Because of the impaired reabsorption of cystine, the amino acid accumulates in the urine at higher concentrations than usual. Cystine is relatively insoluble in urine, especially in acidic conditions, and tends to crystallize. Over time, these cystine crystals can aggregate and form larger cystine stones within the urinary tract. 
• Formation of Cystine Stones: The accumulated cystine crystals in the urine can combine and form stones, called cystine stones or cystine calculi. These stones may vary in size and may obstruct the urinary tract, causing significant pain and other symptoms. The stones can become lodged in the kidneys, ureters, or bladder, leading to urinary tract blockages and potential complications such as infection and kidney damage. 
• Recurrent Stone Formation: Cystinuria is often associated with recurrent stone formation throughout an individual’s life. The frequency and severity of stone episodes can vary among affected individuals, with some experiencing frequent stone formation and others having less frequent episodes. 

Etiology

Cystinuria is primarily caused by genetic mutations that affect the transport of specific amino acids, including cystine, in the kidneys and urinary tract.  

• Autosomal Recessive Inheritance: Cystinuria follows an autosomal recessive inheritance pattern caused by mutations in genes located on autosomal chromosomes (non-sex chromosomes). To develop cystinuria, an individual must inherit two copies of the mutated gene, i.e., one from each parent. Suppose both parents carry one copy of the mutated gene but do not have cystinuria themselves (known as carriers). In that case, they have a 25% chance of having an affected child with cystinuria in each pregnancy. 
• SLC3A1 and SLC7A9 Genes: The genetic mutations associated with cystinuria are primarily found in two genes: SLC3A1 and SLC7A9. These genes code for proteins that play a crucial role in the reabsorption of specific amino acids, including cystine, within the renal tubules of the kidneys. Mutations in either of these genes can disrupt the transport proteins’ normal functioning in amino acid reabsorption. 
• Dysfunction in Amino Acid Transport: The mutations in SLC3A1 and SLC7A9 result in the malfunction of transport proteins in the cells lining the renal tubules. These transport proteins are responsible for reabsorbing cystine and other affected amino acids from the urine into the bloodstream. When these proteins do not function properly due to genetic mutations, there is reduced reabsorption of cystine and other amino acids, leading to their increased excretion in the urine. 
• Elevated Urinary Cystine Levels: The primary consequence of these genetic mutations is cystine accumulation in the urine at higher concentrations than usual. Cystine is relatively insoluble in urine and tends to crystallize when its concentration is too high. Over time, these cystine crystals can combine and form cystine stones within the urinary tract. 

Genetics

Prognostic Factors

The prognosis for individuals with cystinuria can vary depending on the  several factors, including the severity of the condition, the presence of complications, and the effectiveness of treatment.  

• Genetic Mutations: The specific genetic mutations responsible for cystinuria can impact the prognosis. Some mutations may result in more severe dysfunction of the transport proteins responsible for amino acid reabsorption in the kidneys, leading to a higher risk of stone formation and complications. 
• Stone Formation History: The frequency and severity of stone formation episodes in an individual’s history can indicate their future prognosis. Those who have experienced frequent or extensive stone episodes may be at a higher risk of continued stone formation and related complications. 
• Stone Size and Location: The size and location of cystine stones within the urinary tract can affect the prognosis. Large stones or stones that block the urinary tract can lead to more significant complications and may require more invasive treatments. 
• Response to Treatment: The effectiveness of treatment strategies, such as increased fluid intake, dietary modifications, and medication (e.g., thiol drugs), can influence the prognosis. Individuals who respond well to treatment and effectively manage their cystinuria will likely have a better prognosis. 
• Compliance with Medical Advice: Adherence to medical recommendations, including dietary changes and medication regimens, is crucial for managing cystinuria and preventing stone formation. Individuals who consistently follow their healthcare provider’s advice have a more favorable prognosis. 
• Age at Diagnosis: Cystinuria is often diagnosed in childhood or adolescence. Early diagnosis and management can help avert complications and minimize the disorder’s impact on an individual’s health. 
• Complications: Complications of cystinuria, such as recurrent urinary tract infections, kidney damage, or the need for multiple surgical interventions, can negatively affect the prognosis. Prompt treatment and prevention of complications are essential. 
• Family History: A family history of cystinuria can influence the prognosis, as it may indicate an increased risk of the condition in other family members and may require genetic counseling and screening. 

Clinical History

• Age Group: 
• Infants and Young Children: Cystinuria may present in infancy or early childhood with urinary symptoms such as hematuria (blood in the urine), frequent urinary tract infections, or irritability during urination. However, stone formation is less common in this age group. 
• Adolescents and Young Adults: Cystinuria is often diagnosed during adolescence or early adulthood, when individuals are more likely to experience their first episodes of cystine stone formation. The condition tends to be more symptomatic and noticeable in this age group. 
• Adults: Cystinuria can continue to cause stone formation and urinary symptoms throughout adulthood. The frequency and severity of stone episodes may vary among affected individuals. 

Physical Examination

• Abdominal Examination: A healthcare provider may perform an abdominal examination to assess for discomfort or tenderness associated with urinary stone-related pain. They may gently palpate the abdomen to check for any areas of tenderness. 
• Flank Examination: Examination of the flanks can help identify any signs of pain or tenderness indicative of kidney involvement or stone-related pain. 
• Blood Pressure Measurement: Elevated blood pressure may be associated with kidney damage caused by recurrent stone formation. Regular blood pressure monitoring is essential to assess kidney function and overall health. 
• Skin Examination: Although not specific to cystinuria, examining the skin for any signs of rash or dermatological conditions associated with underlying metabolic abnormalities is essential. Some metabolic disorders can manifest with skin changes. 
• Neurological Examination: In rare cases, cystinuria may be associated with neurological symptoms if cystine stones form in the urinary tract and obstruct urine flow. A neurological examination can help assess for any neurological deficits. 
• Growth and Development: Monitoring growth and development is essential for pediatric patients, as cystinuria can manifest in childhood. Delayed growth or developmental issues may be associated with recurrent urinary tract issues. 

Age group

Associated comorbidity

• Dehydration: Dehydration, whether due to inadequate fluid intake or excessive perspiration (e.g., during strenuous exercise or hot weather), can increase the risk of cystine stone formation. Individuals with cystinuria need to maintain good hydration levels. 
• Dietary Factors: High consumption of cystine-rich foods (e.g., red meat and certain dairy products) can exacerbate cystinuria by increasing cystine concentration in the urine. Dietary modifications to reduce cystine intake may be recommended. 
• Urinary Tract Infections (UTIs): Recurrent UTIs can be associated with cystinuria, especially in children. UTIs may be a presenting symptom and should be promptly treated to prevent complications. 
• Family History: A family history of cystinuria is a crucial associated factor, as the condition has a genetic basis. Family members of affected individuals may also be at risk and should consider genetic testing and screening. 

Associated activity

Acuity of presentation

• Acute Pain: The most common acute presentation of cystinuria is the passage of cystine stones. This can lead to severe and sudden pain, often called renal colic, as the stones move through the urinary tract. The pain can be intense and may require medical intervention for pain relief. 
• Hematuria: Blood in the urine (hematuria) can occur during or after the passage of cystine stones. It may be visible as pink, red, or brown urine. 
• Obstruction and Complications: Cystine stones can sometimes obstruct the urinary tract, causing hydronephrosis (kidney enlargement) or kidney damage. Obstructive symptoms, such as difficulty urinating, flank pain, and fever, can also be part of the acute presentation. 

Differential Diagnoses

• Calcium Oxalate Kidney Stones: These are the most common type of kidney stones and can cause symptoms similar to cystinuria. Diagnostic tests, such as stone analysis and urinary calcium and oxalate measurements, can help differentiate between the two conditions. 
• Hypercalciuria: Higher levels of calcium in the urine may lead to the formation of calcium-based kidney stones. Various factors, including dietary choices, medications, or underlying metabolic disorders can cause hypercalciuria. 
• Urinary Tract Infections (UTIs): Infections of the urinary tract can cause symptoms similar to cystinuria, such as urinary urgency, frequency, and pain during urination. UTIs can be distinguished through urine culture and analysis. 
• Uric Acid Stones: Uric acid kidney stones can also cause severe pain and blood in the urine. A 24-hour urine collection and stone analysis can help differentiate between uric acid and cystine stones. 
• Other Metabolic Disorders: Some rare metabolic disorders, such as primary hyperparathyroidism, sarcoidosis, and Dent’s disease, can lead to kidney stone formation. These conditions may require specific tests and evaluations to establish a diagnosis. 
• Inflammatory Bowel Disease (IBD): Conditions like Crohn’s disease and ulcerative colitis can increase oxalate absorption in the intestines, potentially causing kidney stones. 
• Cystitis: Inflammation of the bladder, called as cystitis, can cause urinary symptoms similar to cystinuria. A urinalysis can help differentiate between cystitis and cystinuria. 
• Medication-Induced Stones: Certain medications, such as antiviral drugs and diuretics, can enhance the risk of kidney stone formation. 

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

• Treatment Paradigm 
• The treatment paradigm for cystinuria aims to prevent the formation of the cystine stones in the urinary tract, alleviate symptoms, and minimize the risk of complications. It typically involves a combination of the lifestyle modifications, dietary changes, increased fluid intake, and medication.  
• Hydration: 
• Adequate fluid intake is crucial to dilute cystine concentration in the urine, reducing the risk of cystine crystal formation and stone growth. 
• Patients are often advised to maintain high fluid intake, aiming to produce at least 2.5 to 3 liters (or more) of daily urine. 
• Dietary Modifications: 
• Reducing the intake of cystine-rich foods, such as red meat, fish, eggs, and also dairy products, can help lower urinary cystine levels. 
• Medications: 
• Thiol drugs, such as D-penicillamine and tiopronin, are often prescribed to reduce cystine concentration in the urine by increasing solubility. These medications must be taken under the supervision of a healthcare provider. 
• Alkalinizing agents like potassium citrate or sodium bicarbonate may make the urine less acidic, which can help prevent cystine crystal formation. 
• Regular Monitoring: 
• Routine follow-up visits with a healthcare provider are essential to monitor urinary cystine levels and overall kidney health. 
• Patients may undergo 24-hour urine collection and regular blood tests to assess medication effectiveness and detect complications. 
• Pain Management: 
• During episodes of renal colic (severe pain due to stone passage), pain management medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or opioids, may be prescribed to alleviate discomfort. 
• Surgical Intervention: 
• Surgical intervention may be necessary in cases of large or obstructive cystine stones that do not respond to conservative treatments. This can involve extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, or percutaneous nephrolithotomy (PCNL) to remove or break up the stones. 
• Genetic Counseling and Family Screening: 
• Genetic counseling might be recommended for individuals with cystinuria and their families to understand the genetic basis of the condition and the risk of passing it on to future generations. 
• Family members may undergo genetic testing to determine if they carry cystinuria-associated genetic mutations. 
• Education and Lifestyle Management: 
• Patients and their families should receive education on the importance of adherence to treatment, dietary modifications, and maintaining good hydration. 
• Lifestyle management, including avoiding excessive salt and maintaining a healthy body weight, can help diminish the risk of stone formation. 

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-the-non-pharmacological-therapy-for-modifying-the-environment

• Modifying the environment and making specific lifestyle changes can play a crucial role in managing cystinuria by reducing the risk of stone formation and minimizing the condition’s impact on an individual’s health.  
• Hydration: 
• Adequate fluid intake is one of the most critical environmental modifications for individuals with cystinuria. Drinking plenty of water helps dilute the cystine concentration in the urine and reduces the likelihood of crystal formation. 
• Carry a reusable water bottle and establish a regular drinking schedule to ensure consistent daily hydration. 
• Dietary Modifications: 
• Reducing the consumption of cystine-rich foods can help lower the cystine load in the urine. Such foods include red meat, fish, eggs, and dairy products. 
• Consult with a registered dietitian or nutritionist to create a personalized dietary plan that minimizes cystine intake while ensuring a balanced and healthy diet. 
• Salt Restriction: 
• Reducing salt (sodium) intake can help prevent the buildup of sodium-cystine crystals in the urine. Avoiding excessively salty foods and reading food labels for sodium content can be beneficial. 
• Alkalinizing Agents: 
• Some individuals may benefit from alkalinizing agents like potassium citrate or sodium bicarbonate, which make the urine less acidic. This can help prevent cystine crystal formation. 
• Medication Adherence: 
• If prescribed medications (e.g., thiol drugs) to reduce cystine levels in the urine, it is essential to take them as directed by a healthcare provider. 
• Establish a medication routine to ensure consistency and set reminders if needed. 
• Physical Activity: 
• Regular physical activity can contribute to overall health and help maintain a healthy body weight, which is essential for individuals with cystinuria. 
• Stress Management: 
• Stress can exacerbate symptoms and may contribute to stone formation in some cases. Stress-reduction techniques such as mindfulness, meditation, or yoga can be beneficial. 
• Avoid Dehydration Triggers: 
• Be mindful of activities or environmental factors that may lead to dehydration, such as excessive heat, strenuous exercise, or certain medications (e.g., diuretics). Take precautions to stay hydrated during such situations. 
• Regular Follow-Up: 
• Maintain regular follow-up appointments with healthcare providers, including urologists and nephrologists, for ongoing monitoring and adjustments to your treatment plan as needed. 
• Genetic Counseling and Family Education: 
• Consider genetic counseling if you have a family history of cystinuria to understand the genetic basis of the condition and its implications for family members. 
• Educate family members about the importance of early diagnosis and management. 

Use of medical care for treating Cystinuria

Medical management plays a crucial role in the treatment of cystinuria, a genetic disorder characterized by the excessive excretion of cystine in the urine, leads to the formation of the cystine stones in the kidneys, bladder, and urinary tract. The primary goal of medical care for cystinuria is to avert the formation of cystine stones and manage related symptoms.  

• Hydration: One of the most important aspects of managing cystinuria is maintaining high fluid intake. Drinking plenty of water which can help dilute the concentration of cystine in the urine, reducing the risk of stone formation. Patients are often advised to consume at least 3 liters (about 13 cups) of water daily. 
• Dietary Modifications: Certain dietary changes can help control cystine excretion. Patients are typically advised to limit the intake of cystine-rich foods, such as red meat, eggs, dairy products, and some types of grains. Reducing sodium intake can also be beneficial, as high sodium levels can increase cystine excretion. 
• Cystine-Binding Medications: Medications that bind with cystine in the urine, making it more soluble and less likely to form crystals, may be prescribed. Two commonly used drugs are tiopronin and penicillamine. These medications need to be taken as prescribed to be effective. 
• Alkalinizing Agents: Alkalinizing medications like potassium citrate or sodium bicarbonate may be prescribed to raise the pH of urine, which can reduce the risk of cystine stone formation. 
• Regular Monitoring: Patients with cystinuria should undergo regular monitoring to assess their cystine levels in the urine and to check for the presence of stones. This allows for adjustments to the treatment plan if necessary. 
• Pain Management: In the event of stone-related pain or discomfort, appropriate pain management strategies, like over-the-counter pain relievers/prescription medications, may be recommended. 
• Lifestyle Modifications: In addition to dietary changes, lifestyle modifications like avoiding excessive salt intake, maintaining a healthy weight, and refraining from excessive alcohol consumption can be helpful in managing cystinuria. 
• Patient Education: It’s essential for individuals with cystinuria to be educated about their condition, including the importance of adhering to their treatment plan, staying hydrated, and recognizing symptoms that may indicate stone formation or urinary tract obstruction. 

Use of Surgical care for treating Cystinuria

• Surgical intervention is sometimes necessary to manage cystinuria when conservative treatments like increased fluid intake and medication fail to prevent stone formation or alleviate symptoms.  
• Extracorporeal Shock Wave Lithotripsy (ESWL): It is a non-invasive procedure that generally uses shock waves to break up cystine stones into smaller fragments that can pass easily through the urinary tract. This approach is generally used for smaller stones located in the kidneys or upper urinary tract. 

• Ureteroscopy: Ureteroscopy involves the use of a thin, flexible tube with a camera (ureteroscope) to access and remove stones in the ureters or bladder. In some cases, laser lithotripsy can be employed to break up larger cystine stones during the procedure. 
• Percutaneous Nephrolithotomy: It is a minimal invasive surgical procedure used for larger kidney stones that cannot be effectively treated with ESWL or ureteroscopy. It involves making a small incision in the back and using specialized instruments to remove or break up the stones. 
• Open Surgery: In rare and severe cases where other treatments are not effective or when there are complications like infection or blockage, open surgery may be required.  
• Cystine-Binding Medications: While not a surgical procedure, some patients with cystinuria may be prescribed medications that help reduce cystine stone formation by increasing the solubility of cystine in the urine. These medications, such as tiopronin or penicillamine, can be an important part of long-term management. 
• Preventive Measures: Regardless of the surgical intervention chosen, it is essential for individuals with cystinuria to continue preventive measures like maintaining high fluid intake, dietary modifications, and adhering to medication regimens to reduce the recurrence of cystine stones. 

Use of Cystine-Lowering Medications for treating Cystinuria

• Cystinuria is a genetic disorder characterized by the excessive excretion of cystine (an amino acid) in the urine, which can leads to the formation of the cystine stones in the kidneys, bladder, and urinary tract. Cystine-lowering medications are a crucial component of the treatment plan for individuals with cystinuria. These medications aim to reduce cystine excretion and lower the risk of stone formation.  
• Tiopronin: 
• Tiopronin is a medication that helps reduce cystine excretion by forming a complex with cystine, making it more soluble in urine and less likely to form crystals. 
• It is typically taken multiple times a day with meals and is usually started at a low dose, which may be gradually increased to find the most effective dose for each individual. 
• Regular monitoring of cystine levels in the urine is necessary to adjust the medication dosage as needed. 
• Possible side effects of tiopronin may include gastrointestinal symptoms, skin rashes, and a metallic taste in the mouth. 
• Penicillamine (Cuprimine): 
• Penicillamine is another medication that can bind with cystine to increase its solubility in urine, reducing the risk of stone formation. 
• Like tiopronin, penicillamine is typically started at a low dose and gradually increased under medical supervision. 
• Regular monitoring of cystine levels and liver function is essential while taking penicillamine. 
• Side effects of penicillamine may include gastrointestinal discomfort, skin rashes, and the risk of more serious adverse reactions in some individuals. 
• Captopril: This medication, commonly used to treat hypertension, can also help reduce cystine levels in some cases. 

Use of Extracorporeal shockwave lithotripsy for treating Cystinuria

• Extracorporeal Shockwave Lithotripsy (ESWL) is a non-invasive procedure generally used to break down kidney stones into smaller fragments so that they can be passed more easily through the urinary tract. ESWL can be a treatment option for people with cystinuria who have kidney stones that are suitable for this type of intervention.  
• Patient Assessment: Before undergoing ESWL, the patient’s urologist will assess the size, location, and number of cystine stones in the kidneys. ESWL is most effective for smaller stones (usually less than 2 centimeters) located in the kidney or upper ureter. 
• Preparation: The patient may need to fast for a few hours before the procedure, and they will typically receive pain-relief medication and possibly sedation or anesthesia to ensure comfort during the procedure. 
• ESWL Procedure: During ESWL, the patient lies on a treatment table, and the urologist uses a machine that generates shockwaves to target and break down the kidney stones. These shockwaves are focused precisely on the stones to fragment them. The procedure is usually performed as an outpatient process and can take around 45 minutes to an hour. 
• Recovery: After the procedure, the patient may need some time to recover from the anesthesia or sedation. There may be some discomfort or pain, and the patient may pass stone fragments in their urine over the next few days to weeks. Pain medication and plenty of fluids are often prescribed to help manage any discomfort. 
• Follow-up: It’s essential to have follow-up appointments with the urologist to monitor the progress of stone passage and to determine whether additional treatments are needed. Sometimes, multiple ESWL sessions are necessary to completely fragment and pass the stones. 

use-of-intervention-with-a-procedure-in-treating-cystinuria

• Interventional procedures are sometimes necessary to manage cystinuria, mainly when conservative treatments and lifestyle modifications do not effectively prevent or address the formation of cystine stones in the urinary tract. These procedures are typically performed by urologists and aim to remove or treat existing stones, alleviate symptoms, and reduce the risk of complications. Here are some standard interventional procedures used in the treatment of cystinuria: 
• Extracorporeal Shock Wave Lithotripsy (ESWL): 
• It is a non-invasive procedure that uses shock waves to break cystine stones into smaller fragments. It is often used for smaller kidney or upper urinary tract stones. 
• Ureteroscopy: 
• Ureteroscopy involves the insertion of a thin, flexible tube known as ureteroscope through the urethra and bladder into the ureter or kidney. 
• Once the stone is located, it can be fragmented using laser or pneumatic devices, and the fragments can be removed or allowed to pass naturally. 
• Percutaneous Nephrolithotomy (PCNL): 
• It is a surgical procedure that involves making a tiny incision in the back to access the kidney directly. 
• It is typically used for large or complex cystine stones that cannot be effectively treated with ESWL or ureteroscopy. Stones are broken up and removed through a nephroscope. 
• Laser Lithotripsy: 
• Laser lithotripsy is a technique used during ureteroscopy or PCNL in which a laser is used to fragment cystine stones. 
• The laser energy breaks the stones into smaller pieces, facilitating their removal. 
• Stent Placement: 
• In some cases, a ureteral stent may be placed temporarily to relieve urinary obstruction caused by cystine stones or to assist with stone fragment passage. 
• Chemolysis: 
• Chemolysis involves the use of medications to dissolve cystine stones. These medications may be injected directly into the kidney or delivered through a ureteral catheter. 
• Chemolysis is less commonly used but may be considered for specific cases. 
• Open Surgery: 
• In rare and complex cases where other procedures are not feasible, surgical removal of cystine stones or partial kidney removal (nephrectomy) may be necessary. 

use-of-phases-in-managing-cystinuria

• Managing cystinuria typically involves a phased approach encompassing various aspects of treatment and care to prevent the formation of cystine stones, alleviate symptoms, and minimize the risk of complications.  
• Diagnosis and Initial Assessment: 
• This phase involves the initial evaluation and diagnosis of cystinuria. Healthcare providers may perform urine tests, imaging studies, and genetic testing to generally confirm the diagnosis and assess the severity of the condition. 
• Acute Symptom Management: 
• Immediate pain management is a priority in acute symptoms, such as renal colic (severe pain due to stone passage). Pain relief may be achieved with NSAIDs (nonsteroidal anti-inflammatory drugs) or opioids. 
• Hydration and, in some cases, antiemetic medications may be necessary if symptoms include vomiting and dehydration. 
• Lifestyle and Dietary Modifications: 
• Once diagnosed, individuals with cystinuria should implement lifestyle and dietary modifications to diminish the risk of stone formation. 
• Hydration: Encourage consistent and ample fluid intake to maintain dilute urine.  
• Dietary Changes: Work with a registered dietitian to develop a personalized dietary plan that minimizes cystine-rich food intake, such as red meat, fish, eggs, and dairy products. 
• Sodium Restriction: Reducing salt intake can help prevent the formation of sodium-cystine crystals in the urine. 
• Medication Management: 
• Thiol Drugs: These medications, such as D-penicillamine or tiopronin, may be prescribed to increase the solubility of cystine in the urine, reducing cystine stone formation. 
• Alkalinizing Agents: Some individuals may be given alkalinizing agents, like potassium citrate or sodium bicarbonate, to make the urine less acidic and inhibit cystine crystal formation. 
• Medication adherence is crucial for effective management. 
• Monitoring and Follow-Up: 
• Regular follow-up appointments with healthcare providers, including urologists and nephrologists, are essential. Monitoring includes 24-hour urine collection, stone analysis, and blood tests to assess medication effectiveness and kidney function. 
• Genetic counseling may be offered to individuals and their families to discuss the genetic basis of the condition and inheritance risks. 
• Preventive Measures: 
• Continued adherence to lifestyle modifications, hydration, and medication regimens is essential to prevent cystine stone recurrence. 
• Patients should be educated about the importance of maintaining good hydration, especially during activities that may lead to dehydration. 
• Interventional Procedures: 
• When conservative treatments are insufficient or ineffective, interventional procedures like extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrolithotomy (PCNL), or laser lithotripsy may be necessary to remove or break up cystine stones. 
• Surgical Options: 
• Surgical options such as open surgery or nephrectomy (kidney removal) may be considered in complex cases or when other treatments fail. 
• Family Screening and Education: 
• Encourage family members to undergo genetic testing and screening to identify potential carriers of cystinuria-associated genetic mutations. 
• Educate family members about the importance of early diagnosis and management. 

Medication

Future Trends

Media Gallary

References

• Cystinuria – StatPearls – NCBI Bookshelf (nih.gov) 
• Cystinuria – an overview | ScienceDirect Topics 
• Frontiers | Cystinuria: An Overview of Challenges and Surgical Management (frontiersin.org) 
• Orphanet: Cystinuria